Side-by-side financials for BGLC and GH. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BGLC | GH |
|---|---|---|
| Market cap | - | $17.36 B |
| US-listed rank | - | #680 |
| Revenue (latest FY) | $7.42M | $982.02M |
| Net income (latest FY) | -$2.98M | -$416.30M |
| Net margin | -40.2% | -42.4% |
| SEC filings | 140 | 1,131 |
In their latest fiscal years, BioNexus Gene Lab Corp reported $7.42M in revenue while Guardant Health, Inc. reported $982.02M.
Full pages: BioNexus Gene Lab Corp and Guardant Health, Inc., or browse the full rankings.